Cargando…

2632. Duration of viable SARS-CoV-2 shedding in immunocompromised COVID-19 patients during the widespread vaccination era

BACKGROUND: Individuals with COVID-19 who are immunocompromised have been reported to experience prolonged shedding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compared to those who are immunocompetent. However, it remains unclear how long viable SARS-CoV-2 shedding persists...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanai, Osamu, Fujita, Kohei, Hata, Hiroaki, Odagaki, Takao, Mio, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677139/ http://dx.doi.org/10.1093/ofid/ofad500.2244

Ejemplares similares

525. Comparison of the acceptability and safety of molnupiravir in COVID-19 patients aged over and under 80 years
por: Fujita, Kohei, et al.
Publicado: (2023)

Increasing Burden of Nursing Care on the Treatment of COVID-19 Patients in the Aging Society: Analyses During the First to the Third Wave of Pandemic in Kyoto City, Japan
por: Fujita, Kohei, et al.
Publicado: (2021)

Safety of Remdesivir for Patients 80 Years of Age or Older with Coronavirus Disease 2019 (COVID-19)
por: Kanai, Osamu, et al.
Publicado: (2021)

Comparison of the acceptability and safety of molnupiravir in COVID-19 patients aged over and under 80 years
por: Fujita, Kohei, et al.
Publicado: (2023)

Acute rhabdomyolysis in a young woman with moderate COVID-19
por: Fujita, Kohei, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the trajectory of the number of bronchoscopies performed in a tertiary hospital in Kyoto city
por: Fujita, Kohei, et al.
Publicado: (2023)

Quantitative SARS-CoV-2 Antibody Screening of Healthcare Workers in the Southern Part of Kyoto City During the COVID-19 Pre-pandemic Period
por: Fujita, Kohei, et al.
Publicado: (2020)

Options for the SELEX state D$_{s\J}^+(2632)$
por: Barnes, T, et al.
Publicado: (2004)

Duration of viable virus shedding in SARS-CoV-2 omicron variant infection
por: Boucau, Julie, et al.
Publicado: (2022)

Asymptomatic pulmonary cryptococcosis presenting with mixed lesions of infiltrative and nodular shadow in an immunocompromised patient
por: Ito, Takanori, et al.
Publicado: (2022)

Repetitive responses to nanoparticle albumin‐bound paclitaxel and carboplatin in malignant pleural mesothelioma
por: Kanai, Osamu, et al.
Publicado: (2016)

Pulmonary Lymphangitis Carcinomatosa Mimicking Immunotherapy-Related Interstitial Pneumonitis: A Case Report
por: Imakita, Takuma, et al.
Publicado: (2022)

Decreased handgrip strength can predict lung function impairment in male workers: a cross sectional study
por: Kanai, Makiko, et al.
Publicado: (2020)

Is the anomalous decay ratio of D$_{sJ}$(2632) due to isospin breaking?
por: Maiani, Luciano, et al.
Publicado: (2004)

COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report
por: Leung, Wayne F., et al.
Publicado: (2022)

Characteristics and risk factors of prolonged viable virus shedding in immunocompromised patients with COVID-19: a prospective cohort study
por: Kang, Sung-Woon, et al.
Publicado: (2023)

Concurrence of nivolumab‐induced interstitial lung disease and cancer invasion
por: Kanai, Osamu, et al.
Publicado: (2017)

Small cell lung cancer transformation during immunotherapy with nivolumab: A case report
por: Imakita, Takuma, et al.
Publicado: (2017)

Afebrile tension pyopneumothorax due to anaerobic bacteria: Fistula or gas production?
por: Kanai, Osamu, et al.
Publicado: (2021)

No need to hesitate: immune‐related neutropenia and thrombocytopenia that improved by corticosteroids
por: Kanai, Osamu, et al.
Publicado: (2021)

Primary Pulmonary Malignant Melanoma Successfully Treated with Immunotherapy in a 90-Year-Old Patient
por: Fujita, Kohei, et al.
Publicado: (2022)

480. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant among Immunocompromised Patients
por: KAMEGAI, K O H E I, et al.
Publicado: (2023)

1361. The association between antibody responses and prolonged viable SARS-CoV-2 shedding in immunocompromised patients: a prospective cohort study
por: Lim, So Yun, et al.
Publicado: (2023)

PB2632: DILLEMAS AND CHALLENGES IN ITP TREATMENT OF A PATIENT WITH THROMBOTIC AND HEMORRHAGIC EVENTS DEVELOPMENT
por: Smiljanic, Mihailo, et al.
Publicado: (2023)

Nasogastric tube‐administered alectinib achieved long‐term survival in a crizotinib‐refractory nonsmall cell lung cancer patient with a poor performance status
por: Kanai, Osamu, et al.
Publicado: (2017)

Impact of COVID‐19 pandemic on lung cancer treatment scheduling
por: Fujita, Kohei, et al.
Publicado: (2020)

Development of Mycobacterium avium Complex Lung Disease in Patients With Lung Cancer on Immune Checkpoint Inhibitors
por: Fujita, Kohei, et al.
Publicado: (2020)

Mycobacterium farcinogenes infection after fracture repair of the tibia and fibula
por: Kashihara, Eriko, et al.
Publicado: (2022)

Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers
por: Murata, Takayuki, et al.
Publicado: (2021)

Viable virus shedding during SARS-CoV-2 reinfection
por: Letizia, Andrew G, et al.
Publicado: (2021)

Successful management of a lung cancer patient harbouring both EGFR mutation and EML4-ALK fusion gene with disseminated intravascular coagulation
por: Fujita, Kohei, et al.
Publicado: (2021)

Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques
por: Prescott, Joseph, et al.
Publicado: (2018)

Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient
por: Nakajima, Yukiko, et al.
Publicado: (2021)

278. Immunocompromised Patients with Prolonged Viral Shedding of SARS-COV-2
por: Tarabay, Jessica, et al.
Publicado: (2021)

Widespread keratosis pilaris–like eruption in an immunocompromised child
por: Frigerio, Alice, et al.
Publicado: (2019)

2632. Cord Blood Vitamin D and Maternal Vaccination Status Associated with Decreased Laboratory Confirmed Influenza Infections in Infants
por: Betz, Kristina, et al.
Publicado: (2019)

Infectious Norovirus Is Chronically Shed by Immunocompromised Pediatric Hosts
por: Davis, Amy, et al.
Publicado: (2020)

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
por: Aydillo, Teresa, et al.
Publicado: (2020)

Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
por: Yoon, Jin Gu, et al.
Publicado: (2022)

Newly detected liver nodules with a history of colorectal cancer: are they metastatic? Review of 2,632 cases in a single center
por: Zhu, Kai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oue2kvslobfvqqdtvouc0ab27m